Author:
Lou Yuxuan,Hua Yang,Yang Jiaming,Shi Jing,Jiang Lei,Yang Yang
Abstract
Abstract
Objective
To construct a nomogram for predicting the responsiveness of cardiac resynchronization therapy (CRT) in patients with chronic heart failure and verify its predictive efficacy.
Method
A retrospective study was conducted including 109 patients with chronic heart failure who successfully received CRT from January 2018 to December 2022. According to patients after six months of the CRT preoperative improving acuity in the left ventricular ejection fraction is 5% or at least improve grade 1 NYHA heart function classification, divided into responsive group and non-responsive group. Clinical data of patients were collected, and LASSO regression analysis and multivariate logistic regression analysis were used to explore relative factors. A nomogram was constructed, and the predictive performance of the nomogram was evaluated using the calibration curve and decision curve analysis (DCA).
Results
Among the 109 patients, 61 were assigned to the CRT-responsive group, while 48 were assigned to the non-responsive group. LASSO regression analysis showed that left ventricular end-systolic volume, diffuse fibrosis, and left bundle branch block (LBBB) were independent factors for CRT responsiveness in patients with heart failure (P < 0.05). Based on the above three predictive factors, a nomogram was constructed. The ROC curve analysis showed that the area under the curve (AUC) was 0.865 (95% CI 0.794–0.935). The calibration curve analysis showed that the predicted probability of the nomogram is consistent with the actual occurrence rate. DCA showed that the line graph model has an excellent clinical net benefit rate.
Conclusion
The nomogram constructed based on clinical features, laboratory, and imaging examinations in this study has high discrimination and calibration in predicting CRT responsiveness in patients with chronic heart failure.
Publisher
Springer Science and Business Media LLC
Reference23 articles.
1. HaoG WX. Prevalence of heart failure and left ventricular dysfunction in China: the China hypertension survey, 2012–2015[J]. Eur J Heart Fail. 2019;21(11):1329–37.
2. Glikson M, Nielsen JC, Kronborg MB et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy [published correction appears in Eur Heart J. 2022;43(17):1651]. Eur Heart J. 2021;42(35):3427–520.
3. Daubert C, Behar N, Martins RP et al. Avoiding non-responders to cardiac resynchronization therapy:a practical guide [ J]. Eur Heart J 2017,38 (19): 1463–72.
4. Wang Y, Hou XF. JianGang Zhou. Strategies to improve the efficacy of cardiac resynchronization therapy. Journal of Nanjing Medical University(Natural Sciences),2016,36(4):395–401.
5. Min GU, Han JIN, Wei HUA et al. Clinical features and outcomes of Cardiac Resynchronization Therapy in 16 patients with dilated-phase hypertrophic cardiomyopathy. Chin Circulation J 2017,32(5):461–4.